RankingsPricing
  1. US-listed companies
  2. RESMED INC
  3. Raw

RESMED INCRMD

Market cap
$36.7B
P/E ratio
SummaryFinancials
Back to summarized table
Jun 30,
2011		Jun 30,
2012		Jun 30,
2013		Jun 30,
2014		Jun 30,
2015		Jun 30,
2016		Jun 30,
2017		Jun 30,
2018		Jun 30,
2019		Jun 30,
2020		Jun 30,
2021		Jun 30,
2022		Jun 30,
2023		Jun 30,
2024		Jun 30,
2025
Net income2272553073453533523423164056224757798981,0211,401
Depreciation and amortization718678737387112120151155157160165177198
Amortization of right-of-use assets-----------34323937
Stock-based compensation costs (note 10)313138434846464852586465718092
(Gain) loss attributable to equity method investments, net of dividends received (note 6)--------------24
(Gain) loss on equity investments (note 6)--------------4-10
Restructuring expenses (note 17)-------------33-
Gain on insurance recoveries------------20--
Accounts receivable---352827643218-54129-1910713477
Inventories-11-19-2716100-3042-1847022312249-17280
Prepaid expenses, net deferred income taxes and other current assets-92529-623-1219161485958168138115-83
Accounts payable, accrued expenses and other-1373303864635201-27-23211-2483112291
Net cash provided by operating activities283383403----5054598027373516931,4011,752
Purchases of property, plant and equipment674764736359626369951031351209990
Patent registration costs678899999111421141511
Business acquisitions, net of cash acquired225354291,042719512839431,013133139
Purchases of investments (note 6)252111196144732222132136
Proceeds from exits of investments (note 6)4----------7415
Proceeds / (payments) on maturity of foreign currency contracts----2318-315014-1917-1510-42
Net cash used in investing activities-77-102-78-----102-1,076-180-158-230-1,160-270-200
Proceeds from Issuance of Common Stock956269333928302337483847495374
Taxes paid related to net share settlement of equity awards-----------5231918
Purchases of treasury stock163393186202160102-5423----150300
Payments of business combination contingent consideration---101120104-211
Acquisition of consolidated subsidiary--------------11
Proceeds from Issuance of Long-Term Debt982701505581801,1404503501,5191,190902881,070105-
Repayment of borrowings1241261005601822845451,1467121,28461216640583540
Dividends paid--97142157168186199212225227245258282311
Net cash (used in) provided by financing activities-79-177-154-----1,027581-317-765-128423-1,119-606
Effect of exchange rate changes on cash------------14-2-226
Net increase (decrease) in cash and cash equivalents---------42316-168-22-4610971
Income Taxes Paid, Net---90496993171243180221478217278214
Interest paid-------2836402422474628
Fair value of assets acquired, excluding cash---------1517163604644
Liabilities assumed---19801-26542513286
Goodwill on acquisition--------79420253978792101
Deferred payments-----------4-33-01
Fair value of contingent consideration----2132--4--2-41
Cash paid for acquisitions2253-4291,042719512844431,015135140